Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Medicenna Therapeutics Corp (TSE:MDNA)

TSX:MDNA

MDNA

Medicenna Therapeutics Corp

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding TSE:MDNA?

Track your performance easily

Link Broker

Medicenna Therapeutics Corp (MDNA) Income Statement

192 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q2 2025), Medicenna Therapeutics Corp's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Medicenna Therapeutics Corp's net income was C$-4.16M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 18.34M	C$ 18.67M	C$ 16.30M	C$ 27.38M	C$ 17.39M	C$ 8.24M
Operating Income	C$ -18.34M	C$ -18.67M	C$ -16.30M	C$ -27.38M	C$ -17.39M	C$ -8.24M
Net Non Operating Interest Income Expense	C$ 1.22M	C$ 1.20M	C$ 262.00K	C$ 69.00K	C$ -314.00K	C$ -7.00K
Other Income Expense	C$ 9.41M	C$ 7.92M	C$ -4.35M	-	C$ -208.00K	C$ -39.00K
Pretax Income	C$ -26.68M	C$ -25.47M	C$ -10.05M	C$ -27.14M	C$ -17.29M	C$ -8.28M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -26.68M	C$ -25.47M	C$ -10.05M	C$ -27.14M	C$ -17.29M	C$ -8.28M
Basic EPS	C$ -0.37	C$ -0.37	C$ -0.16	C$ -0.42	C$ -0.35	C$ -0.26
Diluted EPS	C$ -0.37	C$ -0.37	C$ -0.16	C$ -0.42	C$ -0.35	C$ -0.26
Basic Average Shares	C$ 289.74M	C$ 69.64M	C$ 64.74M	C$ 54.29M	C$ 49.66M	C$ 31.90M
Diluted Average Shares	C$ 289.74M	C$ 69.64M	C$ 64.74M	C$ 54.29M	C$ 49.66M	C$ 31.90M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 18.34M	C$ 18.67M	-	-	C$ -17.39M	C$ -8.24M
Net Income From Continuing And Discontinued Operation	C$ -26.68M	C$ -25.47M	C$ -10.05M	C$ -27.14M	C$ -17.29M	C$ -8.28M
Normalized Income	C$ -21.60M	C$ -18.72M	C$ -7.39M	C$ -19.95M	C$ -12.71M	C$ -6.08M
Interest Expense	-	-	-	-	-	-
EBIT	C$ -26.68M	C$ -25.47M	C$ -16.30M	C$ -27.14M	C$ -17.29M	C$ -8.28M
EBITDA	C$ -26.66M	C$ -25.46M	C$ -16.30M	C$ -27.10M	C$ -17.25M	C$ -8.27M

Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing